vs

Side-by-side financial comparison of CHAIN BRIDGE BANCORP INC (CBNA) and Silence Therapeutics plc (SLN). Click either name above to swap in a different company.

Silence Therapeutics plc is the larger business by last-quarter revenue ($15.7M vs $14.7M, roughly 1.1× CHAIN BRIDGE BANCORP INC). CHAIN BRIDGE BANCORP INC runs the higher net margin — 36.4% vs -14.7%, a 51.1% gap on every dollar of revenue.

Suburban Bancorp, Inc. was a publicly traded multibank holding company headquartered in suburban Chicago. It was founded by Gerald F. Fitzgerald, father of former U.S. Senator Peter Fitzgerald, and majority owned by the Fitzgerald family. Bank of Montreal acquired Suburban Bancorp, Inc. by merger in 1994. Harris Bankmont, Inc., an American subsidiary of Bank of Montreal, merged with Suburban Bankcorp to expand the Harris Bank presence in the Chicago area. The all-stock deal was valued at $246...

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

CBNA vs SLN — Head-to-Head

Bigger by revenue
SLN
SLN
1.1× larger
SLN
$15.7M
$14.7M
CBNA
Higher net margin
CBNA
CBNA
51.1% more per $
CBNA
36.4%
-14.7%
SLN

Income Statement — Q4 FY2025 vs Q1 FY2024

Metric
CBNA
CBNA
SLN
SLN
Revenue
$14.7M
$15.7M
Net Profit
$5.3M
$-2.3M
Gross Margin
82.2%
Operating Margin
45.6%
-35.6%
Net Margin
36.4%
-14.7%
Revenue YoY
Net Profit YoY
EPS (diluted)
$0.81
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBNA
CBNA
SLN
SLN
Q4 25
$14.7M
Q3 25
$13.1M
Q2 25
$12.6M
Q1 25
$14.5M
Q3 24
$16.7M
Q1 24
$15.7M
Net Profit
CBNA
CBNA
SLN
SLN
Q4 25
$5.3M
Q3 25
$4.7M
Q2 25
$4.6M
Q1 25
$5.6M
Q3 24
$7.5M
Q1 24
$-2.3M
Gross Margin
CBNA
CBNA
SLN
SLN
Q4 25
Q3 25
Q2 25
Q1 25
Q3 24
Q1 24
82.2%
Operating Margin
CBNA
CBNA
SLN
SLN
Q4 25
45.6%
Q3 25
44.9%
Q2 25
45.8%
Q1 25
48.4%
Q3 24
56.3%
Q1 24
-35.6%
Net Margin
CBNA
CBNA
SLN
SLN
Q4 25
36.4%
Q3 25
35.8%
Q2 25
36.3%
Q1 25
38.6%
Q3 24
44.8%
Q1 24
-14.7%
EPS (diluted)
CBNA
CBNA
SLN
SLN
Q4 25
$0.81
Q3 25
$0.72
Q2 25
$0.70
Q1 25
$0.85
Q3 24
$1.64
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBNA
CBNA
SLN
SLN
Cash + ST InvestmentsLiquidity on hand
$586.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$169.2M
$156.8M
Total Assets
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBNA
CBNA
SLN
SLN
Q4 25
$586.6M
Q3 25
$395.7M
Q2 25
$377.3M
Q1 25
$629.2M
Q3 24
$639.8M
Q1 24
Stockholders' Equity
CBNA
CBNA
SLN
SLN
Q4 25
$169.2M
Q3 25
$163.1M
Q2 25
$156.9M
Q1 25
$151.5M
Q3 24
$104.8M
Q1 24
$156.8M
Total Assets
CBNA
CBNA
SLN
SLN
Q4 25
$1.8B
Q3 25
$1.5B
Q2 25
$1.4B
Q1 25
$1.7B
Q3 24
$1.6B
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBNA
CBNA
SLN
SLN
Operating Cash FlowLast quarter
$15.6M
$-9.1M
Free Cash FlowOCF − Capex
$11.5M
FCF MarginFCF / Revenue
78.1%
Capex IntensityCapex / Revenue
28.0%
0.0%
Cash ConversionOCF / Net Profit
2.92×
TTM Free Cash FlowTrailing 4 quarters
$17.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBNA
CBNA
SLN
SLN
Q4 25
$15.6M
Q3 25
$2.8M
Q2 25
$3.4M
Q1 25
$3.1M
Q3 24
Q1 24
$-9.1M
Free Cash Flow
CBNA
CBNA
SLN
SLN
Q4 25
$11.5M
Q3 25
$2.5M
Q2 25
$2.5M
Q1 25
$1.4M
Q3 24
Q1 24
FCF Margin
CBNA
CBNA
SLN
SLN
Q4 25
78.1%
Q3 25
18.7%
Q2 25
20.0%
Q1 25
9.8%
Q3 24
Q1 24
Capex Intensity
CBNA
CBNA
SLN
SLN
Q4 25
28.0%
Q3 25
2.5%
Q2 25
6.5%
Q1 25
11.6%
Q3 24
Q1 24
0.0%
Cash Conversion
CBNA
CBNA
SLN
SLN
Q4 25
2.92×
Q3 25
0.59×
Q2 25
0.73×
Q1 25
0.55×
Q3 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons